On December 8, 2012, Boehringer Ingelheim Pharmaceuticals, Inc. delivered a presentation at the 54th Annual Meeting of the American Society of Hematology in Atlanta, Georgia. Boehringer Ingelheim presented new findings…
Read More
The German pharmaceutical company responsible for the anticoagulant drug, Pradaxa, offered a $650 million settlement package to wrap up thousands of Pradaxa lawsuits in the U.S. In the statement announcing…
Read More
The U.S. Food and Drug Administration (FDA) recently published a report about the safety of Pradaxa in The New England Journal of Medicine. The article's intention was to more thoroughly…
Read More
August 15, 2009 – Boehringer Ingelheim researchers submitted Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial data to The New England Journal of Medicine October 19, 2010 – Pradaxa approved…
Read More
The latest development in the Pradaxa multidistrict litigation (MDL) in the U.S. District Court for the Southern District of Illinois involves a recently filed court document from mid-September. Both parties…
Read More
A plaintiff in a Pradaxa bleeding risk lawsuit was recently granted approval to move forward with his suit. In the Pradaxa lawsuit, the plaintiff claims that the pharmaceutical company behind…
Read More
Published August 27, 2012 on PR Web St. Louis, Missouri (PRWEB) August 27, 2012 For individuals who have incurred injuries from Pradaxa use, attorneys at Carey Danis & Lowe are…
Read More
New Pradaxa Analysis Underscores Pradaxa Deaths and Urgency of Further Pradaxa Safety Investigations
In January, the Institute for Safe Medication Practices (ISMP) released a report with their safety analysis of three anticoagulant medications, including Pradaxa, warfarin, and Xarelto. The ISMP found that approximately…
Read More
The U.S. Food and Drug Administration (FDA) recently approved a reversal agent to be used in patients experiencing serious and uncontrollable bleeding. The anticoagulation reversal agent is called Kcentra, a…
Read More
Published December 27, 2012 by PR Web St. Louis, MO (PRWEB) December 27, 2012 Pradaxa lawsuits have been consolidated into a Multi-District Litigation being heard in the U.S. District Court,…
Read More